You Can See Everything Trailer: Nathan Fielder’s New Trailer Raises Fresh Questions About Elizabeth Holmes

What the New You Can See Everything Trailer Reveals

The You Can See Everything trailer released this week by comedian‑turned‑filmmaker Nathan Fielder offers a fresh, unsettling glimpse into the mind of former Theranos CEO Elizabeth Holmes. In just a few minutes, the teaser blends archival footage, stark interview snippets, and Fielder’s trademark deadpan humor to set the tone for a documentary that promises both accountability and absurdity. As the trailer rolls, viewers hear Holmes respond to Fielder’s pointed queries about the blood‑testing startup’s lofty promises, the culture of secrecy that surrounded its labs, and the personal toll of the public collapse that still reverberates in 2026.

For fans of investigative storytelling and those still processing the fallout from Theranos, the trailer is a reminder that the story is far from over. It also signals that the documentary will likely explore new angles—particularly the psychological aftermath for Holmes and the lingering questions about regulatory oversight that have only grown more urgent in the wake of recent biotech scandals.

Why Nathan Fielder Is the Ideal Host for This Investigation

Nathan Fielder’s career has long hinged on a blend of satire and genuine curiosity. From his groundbreaking series Nathan for You to his recent forays into documentary filmmaking, he has shown a knack for extracting candid moments from high‑profile subjects. In the trailer, his calm, almost indifferent demeanor creates a stark contrast with the intensity of Holmes’ answers, encouraging viewers to consider the human side of a story that has often been reduced to headlines and courtroom drama.

Fielder’s approach is particularly relevant in 2026, as audiences increasingly demand authenticity over spectacle. By framing his questions in a way that feels both probing and oddly compassionate, he positions the documentary as a bridge between the sensationalism of early Theranos coverage and the nuanced reality of its aftermath.

Elizabeth Holmes: A Figure Still Under Scrutiny

Elizabeth Holmes remains a polarizing figure in the tech and medical communities. While her 2022 conviction for fraud was a watershed moment, the legal and ethical implications of her actions continue to unfold. In 2025, the U.S. Securities and Exchange Commission introduced stricter disclosure requirements for health‑tech startups, a direct response to the Theranos debacle. The documentary’s timing aligns with ongoing debates about how to balance innovation with patient safety, making Holmes’ perspective more pertinent than ever.

In the trailer, Holmes appears reflective, acknowledging mistakes while also defending her original vision. This nuanced portrayal suggests the film will not merely rehash past headlines but will delve into the motivations, pressures, and missteps that led to Theranos’ rise and fall.

What New Angles Does the Documentary Promise?

Beyond the familiar narrative of fraud and courtroom drama, the trailer hints at several fresh investigative angles:

• Internal culture: Fielder’s questions touch on the “cult‑like” atmosphere within Theranos, exploring how loyalty and fear may have silenced dissent.
• Regulatory blind spots: The film appears set to examine gaps in FDA oversight that allowed Theranos to operate with limited scrutiny for years.
• Personal cost: Interviews with family members and former employees suggest a focus on the emotional fallout for those close to Holmes.

These elements promise a documentary that is as much about systemic lessons as it is about an individual’s downfall.

Additional Investigative Themes

Two further themes emerge from the trailer’s visual cues:

1. Data‑driven deception: The teaser shows a montage of lab data screens, hinting that the film will unpack how falsified metrics were presented to investors and board members.
2. Media amplification: A brief clip of a 2020 news broadcast suggests the documentary will critique how early media hype contributed to unchecked growth.

How the Trailer Has Been Received Across Markets

Since its debut on major streaming platforms, the You Can See Everything trailer has sparked conversation in the United States, Canada, the United Kingdom, and beyond. In Australia, early reviews praise the film’s balanced tone, while in Singapore and the United Arab Emirates, critics note its relevance to ongoing discussions about tech regulation. African markets such as Nigeria, South Africa, and Kenya have highlighted the documentary’s potential to inspire local entrepreneurs to prioritize transparency.

Social media buzz reflects a mix of anticipation and skepticism. Some viewers appreciate Fielder’s willingness to confront Holmes directly, while others worry the documentary could veer into “celebrity‑focused” territory rather than delivering hard‑hitting analysis. The varied reactions underscore the global relevance of the Theranos story in 2026.

Practical Takeaways for Entrepreneurs

For startup founders watching the trailer, several practical lessons emerge:

• Document everything: The documentary underscores how the absence of clear, auditable records contributed to Theranos’ downfall.
• Engage regulators early: Proactive dialogue with agencies can prevent the kind of blind spots highlighted in the film.
• Build a culture of dissent: Encouraging employees to voice concerns can surface red flags before they become crises.

These takeaways are framed as actionable advice, making the documentary relevant beyond pure entertainment.

What to Expect When the Full Documentary Drops

The full film is slated for release in early 2027 on a major streaming service, with a limited theatrical run in select cities for awards‑season eligibility. Given the trailer’s tone, audiences can expect a blend of investigative journalism, personal testimony, and moments of dark humor that are characteristic of Fielder’s style.

Industry insiders suggest the documentary could reignite calls for tighter biotech regulation, especially as new startups push the boundaries of at‑home diagnostics. Moreover, the film may influence public perception of female founders, prompting a reevaluation of how gender dynamics intersect with corporate accountability.

Illustrative Example: A Hypothetical Board Meeting

Example: In a recreated board meeting scene, Holmes presents a prototype blood‑testing device while Fielder interjects with a deadpan question about validation protocols. The actors pause, allowing viewers to hear the tension between visionary ambition and scientific rigor. This dramatized example, noted in the trailer, serves to illustrate how internal pressure can suppress critical questioning.

FAQ

When will the full “You Can See Everything” documentary be released?

The documentary is scheduled for a 2027 release, with a streaming premiere followed by a limited theatrical run for awards consideration.

Is the documentary solely about Elizabeth Holmes?

While Elizabeth Holmes is the central figure, the film also examines Theranos’ corporate culture, regulatory failures, and the broader impact on the health‑tech industry.

Where can I watch the trailer?

The official trailer is available on the documentary’s streaming platform and on major video‑sharing sites.

Will the documentary include new interview footage?

Yes, the trailer hints at fresh interviews with former Theranos engineers, legal experts, and members of Holmes’ family, offering perspectives not previously seen in public reports.

How does the documentary address the broader biotech regulatory landscape?

Beyond Holmes’ story, the film explores recent regulatory reforms introduced after 2022, using Theranos as a case study to illustrate why those changes matter for emerging health‑tech companies.

Related reading

• GTA VI Extended Look: a Visual Revolution in Open-world Gaming
• The Witcher 3 Remastered Arrives September 29, 2026—here’s What’s New
• Gamescom Opening Night Live 2026: All the Big Game Trailers and Surprises